دورية أكاديمية
Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis.
| العنوان: | Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. |
|---|---|
| المؤلفون: | Bendele, Alison M., Chlipala, Elizabeth S., Scherrer, Jon, Frazier, Janet, Sennello, Gina, Rich, William J., Edwards, Carl K. |
| المصدر: | Arthritis & Rheumatism; Dec2000, Vol. 43 Issue 12, p2648-2659, 12p |
| قاعدة البيانات: | Complementary Index |
| تدمد: | 00043591 |
|---|---|
| DOI: | 10.1002/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M |